The Management of Heart Failure in Kidney and Urinary Tract Syndromes

Yuri Lopatin, Andrew JS Coats

Abstract


Kidney dysfunction and other related abnormalities are extremely common in all HF syndromes, both because of the similarity of risk factors and the similarity of demography of the two types of patients but also because of the common renal effects of agents used for the treatment of HF. Important renal syndromes for the HF patient include including chronic kidney disease, acute kidney injury, cardio-renal syndrome, and prostatic obstruction. In HF (all types including  HFrEF, HFmrEF and especially HFpEF) chronic kidney disease (CKD) frequently co-exists and almost as frequently complicates the HF management. The two groups of syndromes share many risk factors (diabetes, hypertension, hyperlipidaemia) and often interact to worsen the prognosis of each other in a way that makes the patient with combined HF and renal disease at extremely high risk. This article reviews this common co-morbidity and how to manage it.

Keywords


Heart failure; Kidney disease; Guidelines

Full Text:

450 HTML

References


Damman K, Valente M E, Voors A, O’Connor CM, Van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: An updated meta- analysis. Eur Heart J 2014; 35: 455–469.

Filippatos G, Farmakis D, Parissis J. Renal dysfunction and heart failure: things are seldom what they seem. Eur Heart J 2014; 35: 416–418.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, et al.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592.

Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes. N Engl J Med 2014; 371: 58–66.

Damman K, Testani JM. The kidney in heart failure: an update. Eur Heart J 2015; 36: 1437–1444.

Clark H, Krum H, Hopper I. Worsening renal function during renin- angiotensin- aldosterone system inhibitor initiation and long- term outcomes in patients with left ventricular systolic dysfunction. Eur J Heart Fail 2014; 16: 41–48.

Dorszewski A, Göhmann E, Dorsźewski B, Werner GS, Kreuzer H, Figulla HR. Vasodilation by urapidil in the treatment of chronic congestive heart failure in addition to angiotensin- converting enzyme inhibitors is not beneficial: results of a placebo- controlled, double- blind study. J Card Fail 1997; 3: 91–96.

The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone. JAMA J Am Med Assoc 2000; 283: 1967–1975.

Shewan L.G., Coats A.J.S., Henein M. Requirements for Ethical Publishing in Biomedical Journals. International Cardiovascular Forum Journal. 2015;2:2. http://dx.doi.org/10.17987/icfj.v2i1.4




DOI: https://doi.org/10.17987/icfj.v10i0.450

Copyright (c) 2017 Yuri Lopatin

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.